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The strength of the immune response to certain antigens is controlled by immune 
response (Ir) 1 genes, the majority of which are linked to the major histocompatibility 
complex  (MHC)  (1).  In  the  murine  MHC,  the  I  region  of the  H-2  gene complex 
contains genes coding for class II MHC antigens that are recognized by T  cells of the 
helper  (Th)  and  delayed  hypersensitivity-mediating  (Td)  classes;  these  genes  are 
apparently the Ir genes that control immune responses dependent  upon Th and Td 
cells  (1,  2).  Similarly,  the K  and  D  regions of H-2  contain  genes coding  for class I 
antigens that are recognized by cytotoxic T  cells (Tc) and act as Ir genes controlling 
Tc cell responses (3). 
The mechanisms by which  these H-2-coded Ir genes work have been a  matter of 
intense  speculation  based  on  the  knowledge  that  T  cells  responding  to  a  foreign 
antigen must simultaneously recognize a self-MHC antigen  (MHC restriction)  (1-3). 
Three basic hypotheses have been proposed. First, a combination of a certain foreign 
antigen and a self-MHC antigen may not be able to associate on the surface membrane 
of an antigen-presenting cell in a manner required for precursor T  cell stimulation (4, 
5). Second, somatic generation of diversity in genes coding for T cell antigen-receptors 
may involve a selection process that precludes certain germline genes from undergoing 
variation, thus leaving gaps in the repertoire (6, 7). Third, a large repertoire ofT cell 
antigen receptors may be generated, but those T  cell clones expressing receptors that 
react with self-antigens are suppressed. Cross-reactivity of these suppressed clones with 
some foreign antigens would also result  in gaps in the T  cell response repertoire (8- 
10). The first two of these hypotheses can explain apparently simple Ir gene effects in 
which  weak  responses  to  a  foreign  antigen  are  associated  with  a  particular  MHC 
allele.  However, when  tested  in  a  number of examples  (10)  these  hypotheses have 
been shown to be invalid. Furthermore, they cannot cope with more complex effects. 
Here we describe investigations into the murine Tc cell response to vaccinia virus 
in  which  alleles  of the  K  region  of the  H-2  complex  influence  the  strength  of the 
response  associated  with  the  D b allele  (11,  12).  The  results  exclude  the  first  two 
hypotheses outlined above, but are consistent with the third. 
i Abbreviations used in this paper: Ir, immune response; LCMV, lymphocytic  choriomeningitis virus; MHC, 
major histocompatibility complex; MLC, mixed lymphocyte culture; PFU, plaque-forming units; Tc, 
cytotoxic T cells; Td, hypersensitivity-mediating  T cells; Th, helper T cells. 
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Materials and Methods 
Animals.  Mouse strains used were obtained from Olac Ltd., Oxfordshire, United Kingdom, 
or obtained  from the breeding establishment  of the John Curtin  School. Only females older 
than 6 wk were used. The strains of mice, their H-2 haplotypes, and the abbreviations used in 
this paper are given in Table I. 
Viruses.  WR vaccinia virus, ectromelia virus, and Armstrong strain of lymphocytic chorio- 
meningitis virus (LCMV) were grown and titrated as described elsewhere (13,  14). 
Immunization.  Mice were immunized with either 107 plaque-forming units (PFU) of vaccinia 
virus,  104 PFU of ectromelia virus, or 5 ×  105 PFU LCMV, intravenously. 
Generation of Effector Cells.  Spleen cells from mice immunized 6 or 7 d  previously were used 
for primary vaccinia-, eetromelia-, or LCMV-immune Tc cells, respectively (13,  14). 
Cultures  for the generation of secondary vaccinia-immune Tc cells have been described in 
detail elsewhere (15).  Briefly, 8 ×  107 spleen cells from mice immunized with vaccinia at least 
21  d  previously were co-cultured for 5 d  with  1 ×  107 vaccinia-infected stimulator spleen cells 
infected  at  a  multiplicity  of  1  PFU/celI.  The  generation  of alloreactive Tc  cells has  been 
described in detail (16).  In all experiments only spleen cells from individual mice were used. 
Target Cells.  Thioglycollate-induced peritoneal  macrophages,  BW cells (H-2k),  L929 cells 
(H-2k),  and  EL-4 cells  (H-2b),  and  methylcholanthrene-induced  fibrosarcoma  cell lines  (12), 
MC57 (H-2~, 2R (H-2KR,Db), D2 (H-2d), 5R (H-2Kb,Dd), and BYR (H-2Kq,D  b) were infected 
with vaccinia, ectromelia, or LCMV virus and labeled with 5XCr, as described in detail elsewhere 
(12,  17). 
Preparation of Neonatally Tolerant Mice.  B10 mice were injected intraperitoneally with 5 ×  107 
adult  (B10 ×  4R)F1 or (B10 ×  BYR)F1 spleen cells not later than 24 h after birth. Spleen cells 
of all adult  tolerant  mice were tested  for persisting  F1  cells, using appropriate  anti-H-2 sera 
plus complement, before in vitro assays for antiviral Tc cells. They were found to be >95% of 
recipient phenotype. 
Preparation of Chimeras.  The method used has been described (18).  Briefly, 950-rad-irradiated 
host mice were reconstituted with a total of 2 ×  107 fetal liver cells from 15-16-d embryos and 
used in experiments after at least 8 wk. In the case of (CBA ×  B6)Fx mice reconstituted with a 
50:50 mixture of CBA and B6 fetal liver cells, the spleen cells were tested at the time of antiviral 
response  assays  with  anti-H-2  sera  and  complement.  Results  cited  are  from  chimeras  with 
<60:40 imbalance of CBA and B6 cells in their spleen cell populations. 
Cold Target Competition.  Macrophage  target  cells  were  labeled  with  51Cr,  infected  with 
vaccinia virus as described  above, and  distributed  at  5  ×  104  cells/well in 0.05-ml  aliquots. 
Unlabeled macrophages were either left uninfected or were infected with 2 PFU/cell vaccinia 
virus (2 X  l06 cells/ml) for 1 h. They were washed twice with complete medium and added in 
TABLE  I 
Strains of Mice Used 
C57BL/10  B10  b  b  b  b  b  b  b 
C57BL/6  B6  b  b  b  b  b  b  b 
B 10.A(2R)  2R  k  k  k  k  k  k  b 
B 10.A(4R)  4R  k  k  k  k  b  b  b 
B10.A(5R)  5R  b  b  b  b  k  k  d 
HTG  HTG  d  d  d  d  d  d  b 
BI0.BYR  BYR  q  k  k  k  k  k  b 
BI0.BR  BR  k  k  k  k  k  k  k 
BALB/c  B/c  d  d  d  d  d  d  d 
D2.GD  D2.GD  d  d  d  d/b  b  b  b 
CBA/H  CBA  k  k  k  k  k  k  k 
A/J  A/J  k  k  k  k  k  k  d 
Abbrevia- 
Strain  tion  K  A,  A  s  E~  J  E~  D 1326  Ir  GENE  CONTROL OF  CYTOTOXIC  T  CELL  RESPONSES 
0.1-ml aliquots/well at  ratios of 1,  2, 4, and 8 times the number of labeled targets.  Vaccinia- 
immune Tc cells were added  in 0. l-ml aliquots/well. The assay was run for 6 h. 
5tCr-release Cytotoxicity Assay.  The methods  used  for the cell lines and  macrophage  targets 
have been described in detail elsewhere (12,  17). The duration  of the assays was 6-12  h.  The 
percent specific lysis was calculated using the formula:  percent specific lysis =  [(experimental 
release -  medium release)/(maximum  release -  medium release)]  X  100.  Data given are the 
means of triplicates. Standard errors of the means were always <5% and are omitted for clarity. 
Significance was determined by Student's t test. 
Results 
Presence of K k Affects Db-restricted  Anti-Vaccinia Responses.  Four strains  of mice, each 
carrying the H-2D b allele but possessing different H-2K alleles [B10  (Kb),  HTG  (Ka), 
BYR  (Kq),  and  4R  (Kk)]  were  tested  on  a  panel  of vaccinia-infected  macrophage 
targets for their ability to generate primary Db-restricted  vaccinia-immune Tc cells in 
vivo. Table II illustrates a  typical example of such an experiment  and confirms earlier 
reports (1 1,  12). B 10, BYR, and HTG  Tc cells lysed vaccinia-infected targets efficiently 
when  H-2D b was  shared  by  donors  of Tc cells and  targets.  In  contrast,  4R  Tc cells 
caused  very  little  lysis  of  vaccinia-infected  targets  such  as  B10,  HTG,  and  BYR 
although  they  also  share  H-2D b.  Nonetheless,  4R  effectors strongly  lysed  4R  or BR 
vaccinia-infected  targets,  demonstrating  that  4R  animals  are  immunocompetent  in 
respect  to  vaccinia  and  H-2K k.  The  low responsiveness  of 4R Tc cells in  relation  to 
vaccinia-D  b varied in magnitude  between individual  mice and  ranged  from 3- to 20- 
fold lower lysis of vaccinia-D  b targets  compared  with B10 Tc cells (data  not shown). 
Stimulation ofF1 Lymphocytes  in Parental Recipients.  The possibility that  the defect in 
the anti-vaccinia-D  b Tc cell response in mice expressing K k and  D b antigens is caused 
by low numbers of vaccinia-Db-reactive precursor T  cells was investigated by transfer 
TABLE  II 
Influence of H-2K on Primary H-2D-restricted Anti-Vaccinia Tc Cell Response In  Vivo 
Mouse  H-2K/H-2D  Killer/target 
strain  ratio 
Percent specific lysis of vaccinia-infected 
macrophage targets* 
B10  BR  4R  HTG  BYR 
(KbD  h)  (KkD  k)  (KkD  b)  (KaD~  (KqD  b) 
B10  b/b  45:1  75  2  47  51  49 
I5:1  57  4  42  34  38 
5:I  32  0  15  12  27 
HTG  d/b  45:1  61  0  51  86  64 
15:1  41  0  52  75  51 
5:1  34  0  37  49  39 
BYR  q/b  45:1  48  2  50  39  87 
15:1  34  0  29  38  73 
5:1  24  7  22  18  52 
4R  k/b  45:1  12  67  75  18  25 
15:1  6  52  61  17  15 
5:1  2  18  34  11  16 
* Mean percent 5~Cr-release from  vaccinia-infected targets  over a 6-h period.  Spontaneous 
release ranged from  17 to 29%. Means of triplicates  are given; SE of the means were never 
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of (B10 ×  4R)F1 spleen cells into 950-rad irradiated parental recipients. The recipient 
mice  were  inoculated  intravenously with  vaccinia virus  3  h  post-transfer  of spleen 
cells. Cytotoxicity in spleens was tested 6 d  after infection on macrophage target cells. 
Table III shows  two  representative examples of such  experiments.  The  main  points 
are: F 1 cells transferred into B 10 recipients responded to vaccinia-D  b (D2.GD targets) 
with strength comparable to that of B10 cells in B10 recipients. When F1 spleen cells 
were transferred into 4R or F1 recipients, the anti-vaccinia-D  b response was relatively 
weak.  These  results indicate that  (B10  ×  4R)F1  mice do  not lack the  precursors  to 
respond to vaccinia-D  b, but that the environment determines whether or not the full 
potential of these precursors is expressed, as shown previously by others (11). 
Generation  of Secondary  Vaccinia-immune  Tc  Cells  In  Vitro  in  the  Presence  or  Absence  of 
K k.  The previous experiments (Table III) showed  that  generation of anti-vaccinia- 
D b effector Tc cells from their precursors was inefficient in an environment containing 
K u, but did not distinguish between two possibilities. First, vaccinia-D  b "complexes" 
may not be displayed immunogenically in the presence of K k. This possibility is not 
refuted  by  the  fact  that  anti-vaccinia-D  b  effector  Tc  cells  can  recognize  and  lyse 
infected  4R  (Kk,D  b)  targets  (Table  II)  because  we  have  reported  two  previous 
examples  of antigenic patterns  that  were  recognized  by  effector  T  cells,  but  were 
inefficient at inducing precursors to respond  (19, 20). 
An  alternative  possibility  is  that  mice  with  K k  may  possess  a  mechanism  that 
suppresses generation of anti-vaccinia O b effector Tc cells. The first of these alterna- 
tives was  tested  by stimulating vaccinia-immune memory spleen cells of B10 or 4R 
TABLE  III 
Stimulation of F1 Lymphocytes in Irradiated, Vaccinia-infected Parental Recipients 
Donor lymphocytes  Recipients* 
Percent specific lysis of vaccinia-infected  macrophage 
targets:~ 
BR  B 10  4R  5R  D2.GD 
(KkD  k)  (KbD  b)  (KkD  b)  (KbD  d)  (KaD  b) 
Experiment 1 
BI0  B10  -2  31  22  34  29 
4R  4R  11  3  16  -8  9 
(B10 × 4R)FI  (B10 × 4R)F1  23  14  24  12  9 
(B10 × 4R)FI  BI0  1  25  13  NT§  23 
(B10 × 4R)FI  4R  10  5  12  -4  8 
Experiment 2 
B10  B10  0  24  10  20  14 
4R  4R  9  -3  18  -1  2 
(B10 × 4R)F1  (B10 × 4R)FI  15  24  24  26  1 
(BI0 × 4R)F1  B10  7  17  11  15  10 
(B10 × 4R)F1  4R  12  6  21  8  2 
* Animals were irradiated with 950 rad from a C'°Co source, given 5 ×  l0  7 spleen  cells  18 h  later,  and 
immunized with WR vaccinia after an additional 3 h. Spleen cells were assayed for cytotoxicity  after 6 
d. Irradiated, infected controls that received no spleen cells died before the 6th d. 
~- Mean percent specific 51Cr-release over a 6-h period.  Spontaneous release ranged from 22 to 28%. The 
values given are from titration curves with regression values between 0.9 and 1.1 and were solved at a 
killer/target cell ratio of 15: i. The assay was performed  in triplicates.  Lysis of uninfected targets was not 
significant. 
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origin in  vitro with  vaccinia-infected spleen  cells of either B10  (Kb,Db),  4R  (Kk,Db), 
or BYR  (Kq,D  b)  type  (Table IV). 
Vaccinia-infected  4R cells were similar to infected B 10 or BYR  cells in their ability 
to stimulate  vaccinia-D b Tc  cells  from  either B 10  or  4R  memory  cells,  as  shown  by 
lysis  of infected  BYR  targets.  Thus,  immunogenic  display  of vaccinia-D b  antigens 
takes  place  on  infected  cells  that  also  express  K k.  Simultaneous  generation  of allo- 
reactive Tc cells in allogeneic mixtures did not detract  from this result. 4R  responder 
cells gave about  threefold lower lysis on vaccinia-infected O b targets (B 10, BYR)  than 
did B 10 responders, irrespective of whether  the stimulator cells were infected 4R, B 10, 
or  BYR  spleen  cells.  Presumably  this  result  reflects  relatively  weaker  generation  of 
anti-vaccinia-D b  memory  cells  in  4R  mice,  in  keeping  with  their  weaker  primary 
responses. 
Tc Cell Responses  to  Vaccinia  in Neonatally  Tolerant  BIO Mice.  The  proposition  that 
the presence of K k induces suppression of Tc  cell  responses to vaccinia-D b through  a 
mechanism  of cross-reactive self-tolerance was tested in experiments using B 10 (KU,D  b) 
animals  tolerized neonatally  to K k or K q. 
TABLE  IV 
In  Vitro Cross-Stimulation of Vaccinia-primed Spleen Cells 
Vaccinia-  Percent specific lysis of macrophage targets$ 
Vaccinia-  immune  Killer/  infected  BI0 (Kb,D b)  4R (Kk,D ~)  BYR (Kq,D b) 
memory  stimula-  target 
spleen cell  ratio  tors*  unin-  unin-  unin- 
responders  fected  vaccinia  fected  vaccinia  fected  vaccinia 
B 10  B10 
B10  4R 
B10  BYR 
4R  B10 
4R  4R 
4R  BYR 
30:1  14  41  14  59  8  47 
10:1  14  37  18  56  5  46 
3:1  7  37  5  28  --2  31 
30:1  14  46  44  64  9  57 
10:1  10  46  34  60  3  47 
3:1  6  31  32  38  -2  28 
30:1  9  43  18  62  32  46 
10:l  11  39  16  57  14  47 
3:1  9  23  10  27  l  34 
30:1  40  49  -8  56  15  42 
10:1  33  27  7  54  9  24 
3:1  15  13  -5  37  0  16 
30:1  22  41  -7  64  8  45 
10:l  11  21  --3  55  1  26 
3:1  5  7  --8  46  0  9 
30:1  20  42  --6  56  25  46 
10:1  10  28  -5  58  14  33 
3:1  1  13  --10  48  3  12 
* Spleen cells were infected for 1 h with 1 PFU vaccinia virus and irradiated with 2,000 rad from a ~)Co 
source. 
:~ Mean percent specific 51Cr release over a 6-h period. Spontaneous release ranged from 14 to 16%. Assays 
were performed in triplicates with SE of the mean never >3,7%. MULLBACHER,  BLANDEN,  AND  BRENAN  1329 
B10  neonates  were  injected  intraperitoneally  with  5  ×  107  spleen  cells of (B10  × 
4R)F1,  (B10 ×  CBA)F1,  or (B10 ×  BYR)F1  type no later than  24 h  after birth. At 6 
wk old the mice were infected with vaccinia virus and  tested for vaccinia-immune  Tc 
cells 6  d  later. Table  V  shows a  representative experiment  using cell line targets.  B10 
mice  tolerant  of 4R  (K  k)  or  CBA  (Kk,D  k)  gave  impaired  responses  to  vaccinia-D b 
(HTG-infected  targets)  similar to  the  (B10  ×  4R)F1  control  and  inferior to  the B10 
and  BYR  controls. Their  responses to  vaccinia-K b were similar to  the B10 and  (B10 
×  4R)F1  controls.  In  contrast,  B10  mice  tolerant  of  BYR  (g q)  gave  unimpaired 
responses  to  vaccinia-D b.  The  lack  of  an  anti-vaccinia-K k  response  in  B10  mice 
tolerized  to  4R  or CBA  indicated  no significant  numbers  of (B10  ×  4R)F1  or  (B10 
×  CBA)F1  spleen cells in these mice. 
Further  examples of the effect of tolerance of K k upon  the anti-vaccinia-D b response 
in  B10  mice  are  given in  the experiment  in Table  VI  in  which  macrophage  targets 
were  used,  and  in  which  the  B10  and  4R  controls  were  injected  as  neonates  with 
syngeneic cells. Two  out of the three B 10 mice injected neonatally with (B 10 X  4R)F1 
spleen cells gave impaired  anti-vaccinia-D b responses (infected 4R and  HTG  targets), 
TABLE  V 
Anti-Vaccinia-D b Responses  of Neonatally Tolerized B I O Mice * 
Tolerance  Killer/ 
Responders  treatment  target 
Ratio 
Percent specific  lysis of cell line targets:~ 
L929 (KkD  ~)  5R (KbD  d)  HTG (KdD  b) 
unin-  vacci-  unin-  vacci-  unin-  vacci- 
fected  nia  fected  nia  fected  nia 
BI0  (B10 ×  BYR)F1  45:1  12  8  10  46  2  72 
15:1  6  5  1  33  3  59 
5:1  2  3  4  20  4  25 
BIO  (B10 ×  CBA)F1  45:1  4  1  10  39  3  19 
15:1  1  1  0  14  2  5 
5:t  0  0  2  10  0  4 
B10  (B10 x  4R)F1  45:1  3  1  4  27  3  4 
15:1  3  0  3  16  0  3 
5:1  0  1  3  3  3  3 
B 10  None  45:1  10  7  8  38  1  73 
15:1  3  3  2  11  0  65 
5:t  1  0  1  4  0  35 
BYR  None  45:1  ll  5  8  6  2  71 
15:1  0  6  1  0  2  53 
5:1  0  0  0  0  1  24 
(BI0 x  4R)F1  None  45:1  7  56  15  46  0  4 
t5:1  I  39  8  29  5  4 
5:1  0  15  7  7  2  4 
* Neonates were given 5 ×  107 spleen cells intraperitoneally <24 h after birth. Animals were infected with 
virus at >6 wk old and spleens removed 6 d post-immunization. 
:~ Mean percent specific 51Cr-release from targets over a  10-h period. Spontaneous release ranged from 20 
to 25%. Means of triplicates are given with SE of the mean never >3.7%. 1330  Ir GENE CONTROL OF CYTOTOXIC  T  CELL  RESPONSES 
TABLE  VI 
Anti-Vaccinia-D b Responses of Neonatally  Tolenzed B I O Mice * 
Percent specific lysis of macrophage targets} 
Re-  Tolerance 
sponders  treatment 
Vaccinia-immune effectors 
B10-  BR-  5R-  4R-  HTG- 
Vaccinia  Vaccinia  Vaccinia  Vaccinia  Vaccinia 




4R  B/c 
B10  B10  25  4  51  17  26  86  91 
BI0  23  6  38  21  24  84  87 
4R  4R  0  31  0  27  0  9  54 
4R  0  59  0  43  0  8  58 
B10  (BI0 × 4R)F1  14  0  23  1  6  7  68 
(BI0 × 4R)FI  i4  0  25  6  2  9  41 
(B10 X 4R)F1  23  0  28  26  25  97  87 
* Same procedure in Table V. 
:~ Mean percent specific 51Cr-release over a 6-h period.  Spontaneous release ranged from 21 to 32%. Values 
given are from titration curves with regression  values between 0.9 and  1.1  and were solved at a killer/ 
target  ratio of 15:1. The assay  was  performed in  triplicates.  Lysis of uninfected targets  by vaccinia- 
immune effectors was not significant. 
§ See text for details. 
whereas the third animal was similar to the B10 controls.  Samples of spleen cells from 
the same mice were set up  in one-way mixed-lymphocyte  culture  (MLC)  with either 
4R  or  B/c  irradiated  stimulator  cells  and  tested  after  5  d  on  target  cells  syngeneic 
with  the  stimulators  (last  two  right-hand  columns,  Table  VI).  The  two  mice  with 
impaired  anti-vaccinia-D b responses were apparently  tolerant  of K k  (little lysis of 4R 
targets), whereas the third animal with a  normal anti-vaccinia-D b response was clearly 
not tolerant  of K k. All mice gave substantial  lysis of third-party  B/c targets. 
However,  tolerance  to  K k  did  not  always  produce  an  impaired  anti-vaccinia-D b 
response.  Overall,  29  individual  BI0  animals  treated  with  (BI0  ×  4R)F1  cells  as 
neonates have been evaluated.  3  out of 29 were not  tolerant  to K k, as tested by MLC 
against  4R stimulators,  and  also exhibited normal anti-vaccinia-D b Tc cell responses. 
The  remaining  26  mice  were  tolerant  of  K k.  19  of  these  showed  depressed  anti- 
vaccinia-D  b responses  and  7 gave an appreciable  anti-vaccinia-D u response  (data  not 
shown). 
Virus  Specificity  of Cross-reactive  Tolerance.  Because  tolerance  of K k  could  suppress 
anti-vaccinia-D u Tc cell responses,  but  not  Kk-restricted  responses,  it  was  of interest 
to ask if other H-2Db-restricted  antiviral responses were affected. Table VII shows one 
experiment  using LCMV  in  which  B10 mice tolerized  by  neonatal  injection  of (B 10 
×  4R)F1,  (B10  ×  CBA)FI,  or (B10  ×  BYR)F1  spleen cells gave similar anti-LCMV- 
D b  responses  (lysis  of  2R-LCMV  targets)  to  B10  controls.  All  of these  mice  were 
tolerant  of  K k  or  K q,  as  tested  by  MLC  against  2R,  CBA,  or  BYR  stimulators. 
Because  19 of 26  Kk-tolerant  mice showed  depressed  anti-vaccinia-D b responses,  the 
finding  of  no  depression  of  anti-LCMV-D b  responses  in  4  Kk-tolerized  animals 
indicates that  the phenomenon  probably does not occur with LCMV  (P =  0.012 with 
Fisher's exact test). 
Investigation  of Possible  Cross-Reactivity  Between  K k  and  Vaccinia-D b.  The  evidence MULLBACHER, BLANDEN, AND BRENAN  1331 
TABLE VII 
Anti- L CMV-D b Responses  of Neonatally Tolerized B I O Mice * 
Percent specific lysis  of targets~ 
Re-  Tolerance treat- 
sponders  ment 
LCMV-immune 
effectors  Allogeneic  effectors§ 
2R-  5R-  2R  BYR  L929  D2 
LCMV  LCMV  (Kk,Db)  (Kq,ob)  (Kk,Dk)  (Kd,Dd) 
(Kk,o  b)  (Kb,o  d) 
B  10  None  78  86  NT  23  59  52 
B  10  None  53  68  NT  31  40  48 
B10  (B10 X 4R)FI  50  42  3  NT  NT  23 
BI0  (B10 × 4R)FI  49  40  4  NT  NT  26 
B10  (B10 × CBA)FI  78  72  NT  NT  8  24 
B10  (BI0 × CBA)F1  50  75  NT  NT  7  33 
BI0  (B10 × BYR)F1  55  89  NT  2  NT  24 
* Same procedure in Table V. 
:~ Mean percent specific 51Cr-release from cell line targets over a 10-h period for the anti-LCMV and 6 h 
for the allogeneic response. Spontaneous release ranged from 17 to 27%. The assays were performed in 
triplicate and titrated. Values are given for a killer/target ratio of 15:1 for the anti-LCMV and 3: l for 
the antiallogeneic response. SE of the means were never >5%. Lysis  of uninfected targets was insignificant 
in the LCMV assay. 
§ See text for details. 
presented here suggested the possibility that natural or induced tolerance to K k causes 
suppression of Tc cells that react with vaccinia-D  b, but does not impair responses to 
vaccinia-K  b, vaccinia-K  k, LCMV-D  b, LCMV-K  b, LCMV-K  k, or H-2  d. This evidence 
implicates a  suppressive mechanism with some degree of antigen specificity. There 
would seem  to  be only two  ways  by which  vaccinia-Db-reactive Te  cells could be 
identified: (a) by the ability of their antigen receptors to bind to antigen, or (b) by an 
antiidiotype that binds to the antigen receptors. Therefore, we have looked for Tc cell 
cross-reactivity between K k and vaccinia-D  b  that  would  be  a  corollary of a  and b 
above. Tables II-VI show no indication of significant cross-reactivity of anti-vaccinia- 
D b Tc cells on K k targets.  Table VIII shows  two  representative examples of many 
experiments  that  showed  no  cross-reaction  of MLC-generated  anti-K  k  T  cells  on 
vaccinia-infected H-2  b targets. However, over the course of many experiments it was 
noted that  occasional individual BYR  and HTG  mice generated vaccinia-immune 
effector cell populations that  cross-lysed uninfected H-2  k targets  (data  not shown). 
Because cross-lysis by an  effector  cell  population does  not establish that  the  same 
individual effector cell kills two different target cells, cold target competition experi- 
ments  were  performed  to  test  this  point.  Fortuitously, one  such  experiment  gave 
evidence  of  varying  degrees  of  cross-reactivity  of  anti-vaccinia D b  Tc  cells  with 
uninfected K k competitors in three individual responders (Table IX). The first BYR 
(Kq,D  b)  mouse gave anti-vaccinia-D  b effectors  (lysis of vaecinia-infected B10 [Kb,D  b] 
targets)  that  were  strongly  inhibited by  unlabeled vaccinia-infected B10  (Kb,D  b) 
competitors but showed little cross-inhibition by unlabeled, uninfected 4R (Kk,D  b) or 
BR (Kk,D  k) competitors. In contrast, the second BYR mouse gave effectors that were 
strongly cross-inhibited by unlabeled, uninfected 4R or BR competitors. The HTG 
mouse was intermediate between the 2 BYR animals. 
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TABLE  VIII 
No Apparent  Cross-reactiwty of Anti-K k Tc Cells* on 
Vaccinia-infected H-2 b Targets 
Responder 
Percent specific lysis of targets:~ 
Stimulator  Killer/tar-  BW 
get ratio  (Kk,Dk) 
uninfected 
MC57  (Kh,D  b) 
unin-  vaccinia  fected 
Experiment 1 
B 10(Kb,D  b  )  4R(Kk,D  b  )  30:1  67  10  5 
10:1  55  5  3 
3:l  32  3  -1 
I:1  12  2  1 
Experiment 2 
CBA  B 10 (Kb,D b) 
(Kk,D  k) 
uninfected  uninfected  vaccinia 
B 10(Kb,D b  )  4R(Kk,D b  )  9:1  52  10  12 
3:1  52  4  6 
1:1  29  -1  -2 
* Tc cells were generated in MLC was described in Materials and Methods. 
~: Mean percent specific 51Cr-release  from cell line targets over a  6-h period 
(experiment 1) or from macrophage targets over a  16-h period (experiment 
2). Spontaneous release ranged from  14 to  18% (experiment  l) and from  14 
to 17% (experiment 2). SE of means were never >4.5%. 
TABLE  IX 
Cold Target Competition of Anti-Vaccinia-D 6 Effector Cells 
Percent specific lysis of B 10-vaccinia-infected 
macropbage targets* 
Effectors  Cold competitors 
B 10-Vacei-  BI0  4R  BR  None  nia (Kb,O  b)  (Kb,D  b  )  (Kk,D  b)  (Kk,D  k  ) 
BYR(Kq,D  u)  33  7  33  28  27 
BYR(Kq,D  b)  30  3  31  19  13 
HTG(Kd,D  b)  20  4  22  15  10 
* Mean percent specific 51Cr-release  from B 10-vaccinia-infected target cells in 
the presence or absence of unlabeled competitors over a  6-h period. Killer/ 
target ratio was  15: I. The ratio of competitors to labeled targets was 4: l  for 
the values given. Spontaneous release was  19%. All values are the means of 
triplicates with the SE of the mean never >l.9%. 
that  react  with  both  K k and  vaccinia-D b  antigens  do exist, but  constitute  a  variable 
and  often insignificant  part  of the anti-K k and  anti-vaccinia-D  b Tc  cell repertoires  in 
mice expressing  the H-2D b antigen. 
Comparison  of Strengths of Responses to  Vaccinia-D b and K k in Individual  BIO Mice.  If a 
suppressive  mechanism  operates  upon  the  developing  T  cell  repertoire  to  induce  or 
maintain  self-tolerance  in  normal  animals,  then  it  might  be  expected  that  Tc  cell 
subsets such as anti-K k and  anti-vaccinia-D  b that  can be suppressed  in a  cross-reactive 
manner  (Tables  V  and  VI)  would  exhibit  simultaneous  fluctuation  in  different MULLBACHER,  BLANDEN,  AND BRENAN  1333 
individuals. Therefore, spleen ceils from individual B 10  (Kb,D  b) mice immunized 6 d 
previously with vaccinia virus were tested for anti-vaccinia-D  b activity, and samples 
of the  same  spleen  cells  were  cultured  for  5  d  in  one-way  MLC  with  irradiated 
stimulator cells of 4R  (Kk,D  b)  or B/c  (H-2  d)  type.  Most  of the 40  B10  mice tested 
were  similar  in  their  anti-K  k  and  anti-vaccinia-D  b  responses.  Table  X  shows  two 
selected examples of experiments in which the anti-B/c response was also similar in 
all  three  mice,  thus  indicating  no  general  defect  in  immunocompetence  in  any 
individual. However, in experiment I, all three individual B10  animals gave signifi- 
cantly different anti-vaccinia-D  b responses, of 30, 21, and 6% specific lysis, respectively. 
This variability was mirrored in the anti-4R  (K  k) response with 50,  12, and 7% lysis, 
respectively. The very low response of animal 3 to vaccinia-D  b was the only example 
seen in 50-60  B10 mice tested. In experiment II, animals 2 and 3  gave similar levels 
of lysis in their anti-vaccinia-D  b and anti-4R responses. Animal 1 showed lower anti- 
vaccinia-D  b and anti-4R responses when compared with animals 2 and 3. 
Responses  to Ectromelia-D b in  Chimeric Mice.  The foregoing data are consistent with 
the idea that tolerance of K k results in suppression of anti-vaccinia-D  b responses, but 
do  not  exclude  the  possibility that  other  mechanisms  may  also  contribute  to  the 
phenomenon.  Previous  work showed  that  antiviral Tc  cell responses  are subject  to 
simple feedback regulation, i.e., the effector T  cells mediate destruction of the virus- 
infected  cells  that  present  the  antigenic  patterns  responsible  for  stimulating  the 
generation of effector T  cells (21).  It  follows that  if the effector Tc cell response to 
vaccinia-K  k was generated more quickly than the response to vaccinia-D  b, the latter 
may be suppressed as a  consequence of elimination of the antigenic stimulus by the 
former.  Ectromelia  virus  was  used  to  test  this  hypothesis  because  Tc  cells do  not 
distinguish between vaccinia- and ectromelia-infected cells (13), because it was used 
TABLE X 
Comparison of Anti-Vaccinia-D b Responses with Anti-K k Responses in 
Individual  B I O Mice 
Percent specific lysis of macrophage targets* 
Vaccinia-im- 
Mouse number  mune effectors:~  Allogeneic effectors~: 
4R-Vaccinia  4R  B/e 
(Kk,D  b)  (Kk,Db  (Kd,D  d) 
Experiment  1 
1  30  50  64 
2  21  12  67 
3  6  7  66 
Experiment 2 
1  31  11  32 
2  50  27  37 
3  59  29  29 
* Mean  percent  specific ~lCr-release from  macrophage  targets  over  a  6-h 
period. Spontaneous  release ranged  from 20 to 24%. All values given were 
determined  from a  four point regression curve and solved at  15:1 killer/ 
target cell ratio for the antiviral response, and 3:1 for the allogeneic responses. 
SE of the means were not >3.2%. 
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TABLE  XI 
Responses  to Ectromelia-D b in  (CBA  +  B6)----~(CBA  ×  B6)F1 Chimeras 
Animals*  Killer/Target 
Ratio 
Percent specific lysis of 
ectromelia-infected 
targets~ 
A/Ja  D2GD 
(Kk,D)  (Kd,D  b) 
(CBA + B6) ~  (CBA X B6)F1 mixed  1  9:1  35  22 
chimeras  3:1  28  8 
1:1  6  3 
2  9:1  39  25 
3:1  42  10 
1:1  22  0 
(CBA  x  B6)F1 ~  (CBA  x  B6)F1  1  9:1  39  25 
chimeras  3:1  33  11 
l:l  26  2 
2  9:1  46  23 
3:1  44  9 
1:1  16  13 
(CBA ×  B6)F1  1  9:1  37  25 
3:1  36  9 
1:1  17  2 
2  9:1  23  17 
3:1  11  2 
1:1  12  6 
* Chimeras were  produced  as described  in  Materials and  Methods.  Data  given are  from 
primary responses  in the spleen  6 d  after intravenous injection of 104 PFU of ectromelia 
virus. 
:~ Mean percent specific 5~Cr-release from ectromelia-infected macrophage targets over a  16- 
h period.  Spontaneous release ranged from 30 to 38%. SE of the means were never >5%. 
Lysis of uninfected targets  was not significant. 
for the earlier feedback  regulation  work  (21),  and  because  the  phenomenon  of weak 
anti-ectromelia-D b responses  in mice expressing K k antigen was obtained  (Table XI). 
Feedback  suppression  of this type would only operate  if both  K k and  D b antigens 
were expressed on the same individual virus-infected antigen-presenting cell. It should 
not  operate  in  chimeric mice produced  by reconstituting  lethally irradiated  (CBA × 
B6)F1  hybrids with a  50:50 mixture of fetal liver stem cells from CBA (Kk,D k) and B6 
(Kb,D  b)  mice,  in  which  K k  and  D b  are  expressed  on  separate  cell  populations. 
However, anti-ectromelia-D  b responses  were just  as weak (relative to anti-ectromelia- 
K k  responses)  in  22  such  chimeras  as  they  were  in  normal  F1  mice  or  in  F1  ~  F1 
chimera controls, thus indicating that  feedback regulation was an insignificant  factor. 
Data  from two representative  examples of chimeric mice are given in Table XI. 
Discussion 
In  this  paper  we  have  described  investigations  of several  hypotheses  that  might 
account  for weak anti-vaccinia-D b Tc cell responses  in mice expressing K k and  O b H- 
2 antigens.  These responses  varied from 3-fold to 20-fold lower than  anti-vaccinia-D b 
responses in B10  (Kb,Db),  HTG  (Kd,Db),  and  BYR  (Kq,D  b)  mice, and were also lower 
than  anti-vaccinia-K k responses  in  (Kk,D b)  mice. First, it was apparent  that  the defect 
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vaccinia-infected, Kk-expressing cells in a  manner that allowed recognition and lysis 
by vaccinia-Db-reactive effector Tc cells (Table II) and stimulation of their precursors 
to generate responses (Table IV). Second, the defect was not explained by a  relative 
lack of anti-vaccinia-D  b precursors in mice expressing K k and D b antigens, because T 
cell  populations  from  (B10  ×  4R)F1  (Kk,Kb,D  b)  mice could  give  anti-vaecinia-D  b 
responses comparable to those of B 10 (Kb,D  b) cells if they were stimulated by vaccinia- 
infected B10 cells in lethally irradiated B10 mice (Table III). 
Thus, the simultaneous expression of K k and D b antigens in a  mouse in some way 
results  in  impaired  responses  by  its  anti-vaccinia-D  b reactive  precursors.  Two  hy- 
potheses that might account for this phenomenon were explored further. One hypoth- 
esis was based on feedback regulation  of Tc cell responses  (21).  If anti-vaccinia-K  k 
effector Tc cells were generated more quickly (for some reason) than anti-vaccinia-D  b 
cells, then the latter may be stimulated only weakly because of destruction of virus- 
infected, antigen-presenting cells by the anti-vaccinia-K  k response. This proposition 
was tested  using chimeric mice in  which  the  lymphomyeloid system consisted  of a 
50:50 mixture ofCBA (Kk,D  k) and B6 (Kb,D  b) cells in (CBA ×  B6)F1 hosts. Because 
the K k and D b antigens would now be on different virus-infected, antigen-presenting 
cells,  the  feedback  regulation  outlined  above  would  not  operate.  However,  this 
maneuver did not produce stronger anti-ectrometia-D  b responses  2 than those seen in 
(CBA  X  B6)F1  mice  or  F1  ~  F1  control  chimeras,  thus  refuting  the  hypothesis. 
Feedback regulation has been similarly excluded as an explanation for the phenom- 
enon of parental preference in anti-H-Y Tc cell responses of F1 hybrid mice by using 
mixed parental strain cells as stimulators (22). 
We also tested the hypothesis that natural self-tolerance to K k caused suppression 
of  responses  by  anti-vaccinia-D  b  Tc  cell  precursors,  following  the  precedent  for 
regulation of anti-H-Y Tc cells (17).  Considerable evidence consistent with this idea 
was  obtained.  First,  anti-vaccinia-D  b  precursor  Tc  cell  populations  from  (B10  × 
4R)F1  mice gave good responses  in  irradiated,  vaccinia-infected B10  (Kb,D  b)  hosts 
(comparable to anti-vaccinia-K  k responses from the same F1 T  cell population and to 
anti-vaccinia-D  b responses of B 10 precursors), whereas they gave weaker anti-vaccinia- 
D b responses in 4R  (Kk,D  b)  hosts.  One interpretation  of these data  is that the anti- 
vaccinia D b Tc cell precursors in the F1 donor spleens were released from suppression 
by the process of producing single-cell suspensions and their injection into B 10 hosts, 
and that suppression could be reimposed in irradiated 4R hosts. This interpretation 
might  be subject  to  the  qualification  that  an  allogeneic effect could  improve anti- 
vaccinia-D  b responses of (B 10 ×  4R)F 1 Tc cells in B 10 hosts. However, this possibility 
seems small, because such an effect should be nonspecific, and there was no evidence 
of it on anti-vaccinia-K  b responses (Table III). 
The  most  convincing  evidence  in  favor  of  the  cross-tolerance  hypothesis  was 
obtained using B I0 mice that were neonatally  tolerized  to K k antigens. Of 26 such 
mice, 19 gave anti-vaccinia-D  b responses that were significantly lower than responses 
of normal B10  controls, or B10  mice tolerant  to K q (Tables V  and VI). Natural or 
induced tolerance ~o K k did not affect responses to vaccinia-K  b, vaccinia-K  k, LCMV- 
D b, LCMV-K  b, LCMV-K  k, and H-2  a (Tables V-VII). 
Taken  together,  the  results  discussed  thus  far can  be explained  by a  reversible 
2 Ectromelia and vaccinia are closely related pox viruses that are antigenically indistinguishable by Tc 
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suppressor mechanism that cross-reacts between anti-K  k and anti-vaccinia-D b Tc cell 
precursors, but does not affect the other responses listed above. Suppression with this 
property of partial antigen specificity could be mediated either through cross-reactive 
binding of anti-K k and anti-vaccinia-D b antigen-receptors to K k antigen, or by cross- 
reactive antiidiotypes. It follows that effector Tc cells that cross-react between K k and 
vaccinia-D  b targets should be found. Bidirectional tests of B 10 effector Tc cells failed 
to  demonstrate  such  cross-reactivity  by  target  lysis  (Tables  II-VI, VIII), but  cold 
target competition experiments using some BYR and HTG anti-vaccinia-D  b Tc cells 
showed  that  Kk-expressing competitors  inhibited  lysis of vaccinia-D  b targets  (Table 
IX), thus establishing that the predicted cross-reactivity can exist. 
Although these reactive Tc cells are obviously an insignificant  part of the effector 
Tc cell population generated by the majority of Db-expressing mice, it could be that 
cross-reactive precursors were generated during T  cell ontogeny, and then suppressed 
or deleted as a consequence of self-tolerance mechanisms. If this process took place to 
a  variable  extent  in  different  individual  mice,  then  anti-K  k  and  anti-vaccinia-D  b 
response  capabilities  might  exhibit  simultaneous  variation.  This  phenomenon  was 
found  (Table  X)  by  screening  individual  B10  mice  that  were  similar  in  their  Tc 
responses to a  third-party alloantigen  (H-2d). 
In conclusion, the data presented here are consistent with the idea that the effect of 
K k on anti-vaccinia-D b Tc cell responses is a result of a self-tolerance mechanism that 
cross-reactively suppresses both anti-K  k and anti-vaccinia-D b Tc cell precursors. That 
cross-reactivity  between  anti-K  k  and  anti-vaccinia-D b  effector  Tc  cells  is  rarely 
demonstrable  does  not  deny the  possibility  that  anti-vaccinia-D b precursor Tc cells 
that never give rise to effector progeny are suppressed through cross-reactive binding 
either to K k antigen or to an anti-K  k antiidiotype.  In any case, there are at least  two 
examples of antigenic  patterns  that  are inefficient  at  stimulating  precursor Tc cells, 
but  which  can  be  recognized  by  effector  Tc  cells,  the  generation  of which  was 
stimulated by cross-reacting antigens (19, 20). There is also the precedent  in the H-Y 
system in which neonatal  tolerance caused supression  of a  Tc cell response that  was 
more  cross-reactive  than  the  relevant  effector Tc  populations  (17).  This  work  thus 
constitutes the second investigation consistent with the idea that self-tolerance mech- 
anisms can  mediate  Ir gene effects,  and  illustrates  the power of neonatally  induced 
tolerance as a  tool for elucidating the processes that shape the MHC-restricted T  cell 
repertoire. 
Summary 
The K  region of H-2 controls the Tc cell response to vaccinia-D  b. The K b, K d, and 
K q alleles allow good Tc cell responses against  vaccinia-D b. In contrast, the presence 
of K k in H-2  recombinants  2R  (Kk,D b)  and  4R  (Kk,D b)  or  in  F1  hybrids  greatly 
reduces the anti-vaccinia-D u response. The defect does not lie in antigen presentation, 
as  infected  4R  cells  can  stimulate  anti-vaccinia-D b Tc  ceils  in  vitro.  Furthermore, 
nonresponder  animals  possess  Tc  cell  precursors  for  vaccinia-D  b,  as  transfer  of F1 
nonresponder  spleen  cells  into  infected,  lethally  irradiated  responder  recipients  al- 
lowed generation of anti-vaccinia-D b effector Tc cells. Secondary responses to vaccinia- 
D b can also be obtained in vitro from T  cells of 4R animals.  Feedback inhibition was 
excluded in experiments with mixed chimeras in which K k and D b were expressed on 
separate cell populations. MULLBACHER, BLANDEN, AND BRENAN  1337 
Neonatal tolerance of B 10 animals to K k suppressed the anti-vaccinia-D  b response 
but did not affect anti-vaccinia-K  b, anti-lymphocytic choriomeningitis virus, or anti- 
H-2  d responses. In cold target  competition experiments, H-2  k competitors inhibited 
vaccinia-Db-specific target cell lysis by Tc cells, which suggests that anti-vaccinia-D  b 
and anti-H-2K  k Tc cells may cross-react. Therefore, we propose that the suppressive 
influence of K k on anti-vaccinia-D  b Tc cell responses is a consequence of self-tolerance 
and that suppression of anti-K  k Tc cells results in cross-reactive suppression of anti- 
vaccinia-D  b Tc cells. 
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